NR2F1 controls tumour cell dormancy via SOX9-and RARβ-driven quiescence programmes MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ... Nature communications 6 (1), 6170, 2015 | 301 | 2015 |
Cbx8 acts non-canonically with Wdr5 to promote mammary tumorigenesis CY Chung, Z Sun, G Mullokandov, A Bosch, ZA Qadeer, E Cihan, Z Rapp, ... Cell reports 16 (2), 472-486, 2016 | 105 | 2016 |
The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma C Martínez‐Romero, I Rooman, A Skoudy, C Guerra, X Molero, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 66 | 2009 |
Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis A Bosch, SP Bertran, Y Lu, A Garcia, AM Jones, MI Dawson, EF Farias Breast cancer research 14, 1-19, 2012 | 49 | 2012 |
The Polycomb group protein RING1B is overexpressed in ductal breast carcinoma and is required to sustain FAK steady state levels in breast cancer epithelial cells A Bosch, K Panoutsopoulou, JM Corominas, R Gimeno, G Moreno-Bueno, ... Oncotarget 5 (8), 2065, 2014 | 39 | 2014 |
CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer M Ahmed, F Soares, JH Xia, Y Yang, J Li, H Guo, P Su, Y Tian, HJ Lee, ... Nature communications 12 (1), 1781, 2021 | 38 | 2021 |
Histone H3 lysine 27 crotonylation mediates gene transcriptional repression in chromatin N Liu, T Konuma, R Sharma, D Wang, N Zhao, L Cao, Y Ju, D Liu, ... Molecular Cell 83 (13), 2206-2221. e11, 2023 | 13 | 2023 |
Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer N Bansal, A Bosch, B Leibovitch, L Pereira, E Cubedo, J Yu, ... Oncotarget 7 (28), 43689, 2016 | 11 | 2016 |
NR2F1 controls tumour cell dormancy via SOX9-and RARbeta-driven quiescence programmes. Nat Commun 6: 6170 MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ... Acknowledgment, 2015 | 8 | 2015 |
NR2F1 controls tumour cell dormancy via SOX9-and RARβ-driven quiescence programmes. Nat Commun. 2015; 6: 6170 MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ... | 7 | |
Dysfunction of ubiquitin protein ligase MYCBP2 leads to cell resilience in human breast cancers RA Neff, A Bosch-Gutierrez, Y Sun, I Katsyv, W Song, M Wang, MJ Walsh, ... NAR cancer 5 (3), zcad036, 2023 | 1 | 2023 |
Targeted epigenetic reprogramming reverts tumor progression in triple-negative breast cancer models by the activation of retinoic acid receptor alpha N Bansal, A Bosch, BA Leibovitch, K Pierzchalski, Z Ming-Ming, M Kane, ... Cancer Research 75 (15_Supplement), 3511-3511, 2015 | | 2015 |
NR2F1 controls tumor cell fate via SOX9 and RAR beta driven quiescence and pluripotency programs MS Sosa, Y Estrada, F Parikh, A Bosch, Y Zheng, P Bragado, E Ekpin, ... CLINICAL & EXPERIMENTAL METASTASIS 32 (3), 240-240, 2015 | | 2015 |
Abstract A021: Loss-of-function screen for breast tumor initiating cells reveals PRC1 dependence CY Chung, A Gaspar-Maia, G Mullokandov, A Bosch-Gutierrez, E Farias, ... Molecular Cancer Research 11 (10_Supplement), A021-A021, 2013 | | 2013 |
NR2F1 coordinates a dormancy program by inducing low self-renewal capacity and a repressive chromatin state. MS Sosa, Y Estrada, F Parikh, AB Gutierrez, Y Zheng, P Bragado, E Ekpin, ... Cancer Research 73 (8_Supplement), 1090-1090, 2013 | | 2013 |
NR2F1 and SOX9 mediate reprogramming of tumor cells into dormancy: Potential role in dormant bone marrow DTCs MS Sosa, Y Estrada, F Parikh, A Bosch-Gutierrez, E Ekpin, A George, ... Cancer Research 72 (8_Supplement), 4262-4262, 2012 | | 2012 |
Role of Ring1B in ephitelial to mesenchimal transition, invasion and migration of mammary epithelial cells A Bosch Gutiérrez Universitat Pompeu Fabra, 2009 | | 2009 |
Un caso inusual de carcinoma ductal invasor desarrollado sobre un tumor phyllodes maligno AL Bosch | | |